Does objective short sleep suppress gonadal signaling and lower testosterone in women?

Clinical and epidemiological evidence

• Inconsistent sleep-testosterone relationship: In midlife and perimenopausal women, the impact of insomnia on testosterone is highly variable. Longitudinal path analyses and Mendelian randomization studies show no consistent causal effect of sleep duration or insufficiency on female testosterone levels, unlike the robust declines seen in men.
• Potential protective role of androgens: Large cohort studies, such as the Study of Women's Health Across the Nation (SWAN) and NHANES data, demonstrate that higher endogenous testosterone levels actually protect against sleep fragmentation. Women in the lowest testosterone quartiles experience significantly greater wakefulness after sleep onset and increased reporting of insufficient sleep.

Mechanistic explanations

• HPA-HPG axis crosstalk: Objective short sleep act as a physiological stressor that activates the hypothalamic-pituitary-adrenal (HPA) axis, elevating cortisol levels. This stress response directly inhibits gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) pulsatility.
• Circadian disruption of steroidogenesis: The master circadian pacemaker in the suprachiasmatic nucleus directly regulates GnRH neurons. Disrupted sleep-wake cycles and objective sleep restriction desynchronize this pathway, suppressing downstream gonadal signaling and impairing the ovarian steroidogenesis required for testosterone production.

Bottom line

• While clinical insomnia does not consistently lower testosterone in females, objective short sleep plausibly suppresses gonadal signaling through HPA axis activation and circadian desynchronization, which subsequently compromises downstream testosterone production. For a 49-year-old female navigating the menopausal transition, maintaining adequate sleep duration is crucial to preserve remaining ovarian and adrenal androgen synthesis.